Lifestyle drugs are the medicines that are used to treat lifestyle illness. These are the diseases that rise from our lifestyle choices, which include baldness, impotence, wrinkles, alcoholism or smoking. These conditions are mostly non-threatening and non-painful. Over-the-counter lifestyle drugs can be used to change not only one's appearance, but also one's physical and mental abilities.
Some examples of lifestyle drugs include Viagra (sildenafil citrate), which is used for erectile dysfunction, Latisse and Botox are used as cosmetic related drugs, Provigil (modafinil) used to enhance energy and focus, Yaz and Levora are the U.S. Food and drug administration approved birth control drugs, and Zyban or Chantix are smoking cessation drugs.
Global Lifestyle Drugs Market – Dynamics
The increasing product launches and approvals are expected to boost global lifestyle drugs market growth. For instance, on April 16, 2021, Mayne Pharma released a statement that the U.S. Food and Drug Administration (FDA) approved its Nextstellis, a contraceptive pill that contains E4, a naturally occurring estrogen, has an unusual mechanism of action that maybe more beneficial than other estrogens. Mayne Pharma is dedicated in creating new oral drug delivery systems to produce and distribute branded generic pharmaceuticals, offering better and more accessible medications to the patients.
The increase in use of tobacco and cigarettes among people is expected to drive the global lifestyle drugs market growth. For instance, according to the U.S. Centers for Disease Control and Prevention (CDC), in 2019, cigarettes were smoked by 14.0% of all adults (34.1 million people): 15.3% of men and 12.7% of women and every day, around 1,600 young people try their first cigarette in the U.S.
Rising mergers, agreements, and acquisitions by market players are expected to propel the global lifestyle drugs market over the forecast period. For instance, on January 23, 2020, Greenstone, Upjohn's U.S.-based generics business and a wholly owned subsidiary of Pfizer Inc., and Roman, an innovative digital healthcare clinic for men, officially confirmed a purchase agreement that will provide Roman members with access to the only the U.S. FDA-approved generic form of Viagra (sildenafil citrate). These factors are expected to support global lifestyle drugs market growth over the forecast period.
Global Lifestyle Drugs Market – Regional Insights
Among regions, North America is expected to account for the largest share in global lifestyle drugs market during the forecast period, owing to the rising cases of obesity. For instance, according to the Centers for Disease Control and Prevention, the adult obesity rate in 2019 was 42.4%, which was probably the first time when the national rate surpassed the 40% mark and demonstrated the obesity crisis of the U.S.
Moreover, due to rising collaborations and sales partnerships, Europe region may witness a lucrative growth in global lifestyle drugs market over the forecast period. For instance, on May 3, 2018, Biesterfeld Spezialchemie expanded its extensive product portfolio and strengthened its sales partnership with Sytheon in Europe by adding a unique range of proprietary and patented active ingredients for the cosmetics industry. The areas of expertise primarily address acne, skin ageing, sun protection, and skin hydration. One of the active ingredient, SytenolA is a natural alternative to retinol that has much better skin tolerance, hydrolytic stability, and no photo toxicity. It functions as an anti-oxidant and is ideal for acne-prone skin and anti-aging products. Biesterfeld Spezialchemie GmbH is a leading, global marketer and distributor specialty chemicals in the fields of lifesicene, etc. Sytheon Ltd. is a supplier of active ingredients and an influencer in the personal care industry. These factors are expected to support global lifestyle drugs market growth over the forecast period.
Global Lifestyle Drugs Market – Taxonomy
By Drug Class:
By Dosage Form:
By Distribution Channel:
Global Lifestyle Drugs Market – Competitive landscape
Key players operating in the global lifestyle drugs market include Pfizer Inc, Biesterfeld Spezialchemie GmbH, Roman Inc, Sytheon Ltd., Unilever plc, Johnson & Johnson, Neutrogena Corporation, Oriflame cosmetics, Eli Lily &co, Novo Nordisk A/S, AstraZeneca plc. GlaxoSmithKline plc., and Allergan plc.